Genzyme Leukemia Drug Given FDA Approval
88298
Genzyme Corp. on Wednesday said the Food and Drug Administration gave marketing approval for Clolar, its agent aimed at treating children with leukemia who have failed prior therapies.
438501
Here's what a newly approved drug looks like.
367403
Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney cancer.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
459261
Genta (GNTA:Nasdaq - news - research) is never boring! Monday night, the company announced that its phase III Genasense study in chronic lymphocytic leukemia (CLL) met its primary endpoint, which was tumor shrinkage.
93812
The results from the new clinical trial could increase the chances that the Food and Drug Administration will approve the drug for that use.
131156
LONDON (CBS.MW) -- The US Food and Drug Administration has approved a Genzyme Corp. (GENZ) cancer drug for treating a type of childhood leukemia after other therapies have failed.
340456
A once-a-month drug for treating  multiple sclerosis that appears to cut relapses of the  autoimmune disorder was approved on Tuesday by the U.S. Food  and Drug Administration.
191337
GlaxoSmithKline won permission yesterday from the Food and Drug Administration to sell a tumor-growth inhibitor called Tykerb to treat breast cancer.
671018
Thalidomide received federal approval Thursday for treatment of bone-marrow cancer, marking the further rehabilitation of a drug originally banned more than 40 years ago after it caused thousands of birth defects.
485506
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells. The Food and Drug Administration approved the drug, Zolinza, to treat advanced cases of cutaneous T-cell lymphoma, a rare cancer that's a form of non-Hodgkin's lymphoma. Roughly 20,000 Americans have the cancer, Merck said.
143377
The Food and Drug Administration (FDA) today cleared for marketing the first laboratory test system that will allow physicians to consider unique genetic information from patients in selecting medications and doses of medications for a wide variety of
287736
TORONTO - A new but potentially costly treatment for multiple sclerosis has received fast-track approval from the US Food and Drug Administration.
28028
Genzyme Corp.&#39;s not-yet-completed $1 billion acquisition of Ilex Oncology Inc. appeared to pay off yesterday when an advisory committee to the Food and Drug
295886
The U.S. Food and Drug  Administration said on Wednesday it had approved Amgen Inc's  drug Vectibix for the treatment of advanced colon cancer.
96500
Genzyme Corp. , the biotech firm expanding into the market for cancer treatments, said fourth-quarter revenue rose 23 percent to $591 million on higher sales of its Cerezyme treatment for Gaucher disease. Revenue increased from $481 million a year earlier, the Cambridge company said in an e-mailed statement. Profit for the full year 2004, excluding some items, rose to $1.75 ...
18221
Genzyme has agreed to pay at least $325 million to win the hotly contested rights to a potentially powerful cholesterol-lowering drug.